Concerto Biosciences converts complex microbial ecology data into effective, microbe-based consumer health products. The company utilizes proprietary kChip experimental platforms and kAI modeling to generate and analyze vast ecological datasets for predictable microbial engineering. This intelligence enables the development of high-performance ingredients for applications in skin health and other chronic conditions.
Funding
$25.4M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
SEFounders
Product
Problem
Developing effective microbe-based products is challenging due to the complexity of microbial communities and their interactions. Translating lab results into real-world efficacy for skincare, chronic disease, and nutrition applications remains a significant hurdle.
Solution
Concerto Biosciences utilizes its kChip discovery engine to construct and analyze millions of defined microbial communities, identifying specific microbes, nutrients, and metabolites that drive desired product functions. The company's kAI model learns from vast ecological datasets generated by the kChip, mapping interactions and predicting behavior to enable the development of microbial, prebiotic, and postbiotic products. By understanding and harnessing microbial ecology, Concerto aims to create reliable products with real-world efficacy for various applications. They partner with biotech and biopharma firms to develop transformative products that enhance health outcomes.
Target Audience
Concerto Biosciences primarily targets biotech and biopharma companies seeking to develop innovative microbial-based products.
Features
- kChip discovery engine for constructing and analyzing millions of defined microbial communities simultaneously.
- Identification of specific microbes, nutrients, and metabolites that drive desired product functions.
- kAI model for mapping interactions and predicting behavior within microbial communities.
- Development of microbial, prebiotic, and postbiotic products for skincare, chronic disease, and nutrition applications.
- Focus on translating lab results into real-world efficacy.